| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/15/2010 | US20100092467 Prevention of tissue ischemia, related methods and compositions |
| 04/15/2010 | US20100092466 Combination of zd6474 and bevacizumab for cancer therapy |
| 04/15/2010 | US20100092465 Treatment of graft-versus-host disease |
| 04/15/2010 | US20100092464 M-CSF-Specific Monoclonal Antibody and Uses Thereof |
| 04/15/2010 | US20100092463 Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject |
| 04/15/2010 | US20100092462 Methods for Suppressing Toll-Like Receptor Activity |
| 04/15/2010 | US20100092461 Remedy For Chemotherapy-Resistant Cancer Containing HLA Class I-Recognizing Antibody as the Active Ingredient and Use of the Same |
| 04/15/2010 | US20100092460 Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders |
| 04/15/2010 | US20100092459 Protein Complex and Uses |
| 04/15/2010 | US20100092458 Regulation of apg8 phosphorylation and uses thereof |
| 04/15/2010 | US20100092457 Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies |
| 04/15/2010 | US20100092456 Methods of treatment |
| 04/15/2010 | US20100092455 Novel anti-proliferation antibodies |
| 04/15/2010 | US20100092427 Pyridinone Diketo Acids: Inhibitors of HIV Replication in Combination Therapy |
| 04/15/2010 | US20100092424 Method of diagnosis and treatment of tumors using high intensity focused ultrasound |
| 04/15/2010 | US20100092423 Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 04/15/2010 | US20100092402 Treatment of respiratory disease |
| 04/15/2010 | US20100092388 Anthracycline Derivatives |
| 04/15/2010 | CA2743361A1 Methods and systems for predicting misfolded protein epitopes |
| 04/15/2010 | CA2740248A1 Nicotine immunonanotherapeutics |
| 04/15/2010 | CA2740162A1 Targeting of antigen presenting cells with immunonanotherapeutics |
| 04/15/2010 | CA2740155A1 Adjuvant incorporation in immunonanotherapeutics |
| 04/15/2010 | CA2740124A1 Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
| 04/15/2010 | CA2740046A1 Detection of granulosa-cell tumors |
| 04/15/2010 | CA2739918A1 Methods for inducing a sustained immune response against a b-cell idiotype using autologous anti-idiotypic vaccines |
| 04/15/2010 | CA2739876A1 Phase-transition polymeric microneedles |
| 04/15/2010 | CA2739794A1 Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis |
| 04/15/2010 | CA2739765A1 Vaccine composition for use against influenza |
| 04/15/2010 | CA2739688A1 Composition comprising sortase anchored surface proteins of streptococcus uberis |
| 04/15/2010 | CA2739670A1 Oncostatin m as an enhancer of the immunostimulatory activity of human epithelial cells |
| 04/15/2010 | CA2739122A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/15/2010 | CA2739111A1 Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease |
| 04/15/2010 | CA2737684A1 Oral vaccines for producing mucosal immunity |
| 04/14/2010 | EP2175271A1 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 04/14/2010 | EP2175022A1 Methods of construction biodiverse gene fragment libraries |
| 04/14/2010 | EP2175017A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 04/14/2010 | EP2175016A1 Anti-prominin-1 antibody having adcc activity or cdc activity |
| 04/14/2010 | EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 04/14/2010 | EP2174957A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 04/14/2010 | EP2174956A1 Compositions for anti-fibrinolitic treatment |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174953A1 Compositions and methods for the diagnosis and treatment of tumor |
| 04/14/2010 | EP2174950A1 fermentation process for the production of diphtheria toxin |
| 04/14/2010 | EP2174946A1 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 04/14/2010 | EP2174667A1 Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient |
| 04/14/2010 | EP2174665A2 Compositions and methods for activating innate and allergic immunity |
| 04/14/2010 | EP2174664A1 New virulence factors of Streptococcus pneumoniae |
| 04/14/2010 | EP2174662A2 Methods for treating muscle injuries |
| 04/14/2010 | EP2173912A2 Novel synthetic agonists of tlr9 |
| 04/14/2010 | EP2173902A1 Therapeutics and diagnostics for group a streptococci |
| 04/14/2010 | EP2173896A2 Prognostic method for the determination of the suitability of biopharmaceutical treatment |
| 04/14/2010 | EP2173866A2 Vaccine production for pathogenic bird viral diseases |
| 04/14/2010 | EP2173865A2 Apparatus and method for harvesting biologics from eggs |
| 04/14/2010 | EP2173771A1 Antibodies against human cytomegalovirus (hcmv) |
| 04/14/2010 | EP2173438A2 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 04/14/2010 | EP2173385A1 Chlorotoxins as drug carriers |
| 04/14/2010 | EP2173381A2 Fc receptor-binding polypeptides with modified effector functions |
| 04/14/2010 | EP2173380A2 METHODS AND COMPOSITIONS FOR PULMONARY ADMINISTRATION OF A TNFa INHIBITOR |
| 04/14/2010 | EP2173379A2 Compositions and methods for treating and diagnosing cancer |
| 04/14/2010 | EP2173378A2 Complexes of il-15 and il-15ralpha and uses thereof |
| 04/14/2010 | EP2173377A1 Antibody-endostatin fusion protein and its variants |
| 04/14/2010 | EP2173374A2 Compositions and methods for generating an immune response in a subject |
| 04/14/2010 | EP2173163A1 Antibody formulations |
| 04/14/2010 | EP1748791B1 NEISSERIA MENINGITIDIS IgtB LOS AS ADJUVANT |
| 04/14/2010 | EP1409016B1 Antibodies to opgl |
| 04/14/2010 | EP1406928B1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2010 | EP1399483B1 Antibodies to insulin-like growth factor i receptor |
| 04/14/2010 | EP1305418B1 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/14/2010 | EP1221969B1 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/14/2010 | EP1207199B1 Tumor antigen |
| 04/14/2010 | EP1015596B2 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/14/2010 | EP0961833B1 Human plasma hyaluronidase |
| 04/14/2010 | EP0831903B1 Connective tissue growth factor |
| 04/14/2010 | CN1852690B Medicament conveying system |
| 04/14/2010 | CN1767852B Antibody vaccine conjugates and uses therefor |
| 04/14/2010 | CN101694497A Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 04/14/2010 | CN101693890A Immunostimulatory sequence oligonucleotides and methods of using the same |
| 04/14/2010 | CN101693885A Anti-HBV (hepatitis B Virus) nicotine medicine composition |
| 04/14/2010 | CN101693747A Specific polysaccharide preparation process |
| 04/14/2010 | CN101693742A anti-igf-i receptor antibody |
| 04/14/2010 | CN101693109A Yeast glucan synergistic inactivated vaccine for preventing staphylococcus aureus mastitis in dairy cows |
| 04/14/2010 | CN101693105A Application of IL-4-like recombinant protein of fishes |
| 04/14/2010 | CN101259266B Preadipocyte heterologous vaccine and preparation method and application thereof |
| 04/14/2010 | CN101091799B Medicine in use for treating gastric cancer, and preparation method |
| 04/13/2010 | US7696343 using antagonists to JAM-1 Claudin-4 and occludin; drug delivery; small interfering nucleic acid (siNA) that down-regulates the expression of a junctional adhesion molecule-1 (JAM-1) rnRNA in a respiratory epithelial cell |
| 04/13/2010 | US7696326 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 04/13/2010 | US7696324 Humanized antibodies |
| 04/13/2010 | US7696323 chimeric constructs consisting of constant domains of the IgY heavy chain and mammalian immunoglobulin domains that were found to be responsible for the higher molecular stability of mammalian immunoglobulins under acidic conditions; for peroral therapeutic applications |
| 04/13/2010 | US7696322 Heavy and light chain peptides; generating antibody genes; binding to antigens |
| 04/13/2010 | US7696321 Molecules and methods for inhibiting shedding of KIM-1 |
| 04/13/2010 | US7696317 Mammalian genes; related reagents and methods |
| 04/13/2010 | US7696314 Hypoallergenic mutant polypeptides based on fish parvalbumin |
| 04/13/2010 | US7696310 Peptides for detection of antibody to Anaplasma phagocytophilum |
| 04/13/2010 | US7696308 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria |
| 04/13/2010 | US7696175 Combination cancer immunotherapy with co-stimulatory molecules |
| 04/13/2010 | US7696154 Administering formulation comprising polypeptide and muteins, fused proteins, muteins, functional derivatives and active fragments for treating autoimmune diseases, Type I diabetes, rheumatoid arthritis, graft rejections, inflammatory bowel disease, sepsis, multiple sclerosis, ischemic heart disease etc. |
| 04/13/2010 | US7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/13/2010 | US7695939 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 04/13/2010 | US7695936 Knobs and holes heteromeric polypeptides |
| 04/13/2010 | US7695729 Nonoral preparation having three-layer structure |